+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmacy Market Size, Share & Trends Analysis Report by Product (Prescription, OTC), Type (Retail Pharmacy, ePharmacy), Region (North America, Europe), and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 145 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 5526480
The global pharmacy market size is anticipated to reach USD 2.06 trillion by 2030, growing at a CAGR of 7.28% from 2024 to 2030. This can be attributed to the growing demand for prescription medications due to a trend towards the use of specialty medications, which account for a significant portion of prescription drug spending, and the increasing prevalence of chronic diseases. According to the Assistant Secretary for Planning and Evaluation statistics of September 2022, in 2021, specialty drugs accounted for more than 40% of overall retail drug spending and around 70% of the no-retail drug spending in the U.S.

Technological advancements have transformed the market in recent years. One of the most significant advancements is using Electronic Health Records (EHRs), which allow pharmacists to access and update patient medical information in real-time. This has improved the efficiency and accuracy of prescription filling, reduced errors, and improved patient safety. Another advancement is robotic dispensing systems, which can fill prescriptions quickly & accurately, freeing up time for pharmacists to provide additional patient care services. Telepharmacy is another emerging technology that allows pharmacists to provide remote consultations and prescription filling services to patients in underserved areas. For instance, in November 2020, Amazon launched Amazon Pharmacy to sell prescription drugs in the U.S. Pharmacies are using automation systems and robots for packaging, labeling, filling, and dispensing to improve efficiency and reduce prescription filling time.

Pharmacy Market Report Highlights

  • Based on product, prescription segment held the largest share in 2023. The growing number of prescriptions by healthcare professionals for the treatment of chronic conditions such as cancer, diabetes, and cardiovascular diseases is expected to drive the growth of the segment.
  • Based on type, the retail pharmacy segment accounted for the largest revenue share in 2023. This growth is attributed to the increasing number of independent pharmacies and chains offering various services beyond prescription dispensing, such as vaccination services and health management programs. For instance, CVS Health provides health management programs such as diabetes care and chronic kidney disease (CKD) management, contributing to market expansion.
  • North America dominated the market in 2023 due to factors such as the aging population, increasing demand for prescription medications, and the rise in the adoption of e-pharmacy services.
  • In December 2023, Rite Aid Corp partnered with the Philadelphia Flyers. This partnership aimed to help strengthen Philadelphia Flyer’s brand awareness among fans and visitors to the arena.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.8.2. Volume Price Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing prevalence of chronic diseases
3.3.1.2. Expanding health insurance coverage
3.3.1.3. Technological advancement
3.3.1.4. Increasing demand for specialty drugs
3.3.2. Market Restraint Analysis
3.3.2.1. Product Recalls and Lawsuits
3.3.2.2. Lack of trained staff
3.3.3. Industry Opportunities
3.3.4. Industry Challenges
3.4. Business Environment Analysis
3.4.1. Industry Analysis - Porter’s Five Forces Analysis
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Pharmacy Market: Product Movement Analysis
4.2. Pharmacy Product Market: Segment Dashboard
4.3. Product Movement & Market Share Analysis, 2023 & 2030
4.4. Global Pharmacy Market Estimates & Forecast, by Product
4.5. Prescription
4.5.1. Prescription market, 2018-2030 (USD Billion)
4.6. OTC
4.6.1. OTC market, 2018-2030 (USD Billion)
Chapter 5. Type Business Analysis
5.1. Pharmacy Market: Type Movement Analysis
5.2. Type Market: Segment Dashboard
5.3. Type Movement & Market Share Analysis, 2023 & 2030
5.4. Global Pharmacy Market Estimates & Forecast, by Type
5.5. Hospital Pharmacy
5.5.1. Hospital Pharmacy market, 2018-2030 (USD Billion)
5.6. Retail Pharmacy
5.6.1. Retail Pharmacy market, 2018-2030 (USD Billion)
5.6.2. Chain
5.6.2.1. Chain Pharmacy market, 2018-2030 (USD Billion)
5.6.3. Independent pharmacy
5.6.3.1. Independent pharmacy market, 2018-2030 (USD Billion)
5.6.4. Others
5.6.4.1. Others market, 2018-2030 (USD Billion)
5.7. ePharmacy
5.7.1. ePharmacy market, 2018-2030 (USD Billion)
5.8. Others
5.8.1. Others market, 2018-2030 (USD Billion)
Chapter 6. Regional Business Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. North America Pharmacy Market, 2018-2030 (USD Billion)
6.5.2. U.S.
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. U.S. pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.5.3. Canada
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive scenario
6.5.3.4. Canada pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.5.4. Mexico
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive scenario
6.5.4.4. Mexico pharmacy market estimates & forecast,, 2018-2030 (USD Billion)
6.6. Europe
6.6.1. Europe Pharmacy Market, 2018-2030 (USD Billion)
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. UK pharmacy market estimates & forecast,, 2018-2030 (USD Billion)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive scenario
6.6.3.4. Germany pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive scenario
6.6.4.4. France pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive scenario
6.6.5.4. Italy pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive scenario
6.6.6.4. Spain pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive scenario
6.6.7.4. Sweden pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.6.8. Norway
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive scenario
6.6.8.4. Norway pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework
6.6.9.3. Competitive scenario
6.6.9.4. Denmark pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.7. Asia Pacific
6.7.1. Asia Pacific Pharmacy Market, 2018-2030 (USD Billion)
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. Japan pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. China pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. India pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. Australia pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. Thailand pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.7.7. South Korea
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework
6.7.7.3. Competitive scenario
6.7.7.4. South Korea pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.8. Latin America
6.8.1. Latin America Pharmacy Market Estimates & Forecast, 2018-2030 (USD Billion)
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. Brazil pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive scenario
6.8.3.4. Argentina pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.9. MEA
6.9.1. MEA Pharmacy Market Estimates & Forecast, 2018-2030 (USD Billion)
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. South Africa pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. Saudi Arabia pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. UAE pharmacy market estimates & forecast, 2018-2030 (USD Billion)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Regulatory framework
6.9.5.3. Competitive scenario
6.9.5.4. Kuwait pharmacy market estimates & forecast, 2018-2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. Expansion
7.2.2. Merger & Acquisition
7.2.3. New Service Launch
7.2.4. Partnership/Collaborations
7.2.5. Others
7.3. Company market position analysis
7.4. Company Profiles/Listing
7.4.1. CVS Health
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Boots Walgreens
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Cigna
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Walmart
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Kroger
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Rite Aid Corporation
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Lloyd Pharmacy
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Well Pharmacy
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.8.5. Strategic Initiatives
7.4.9. Humana Pharmacy Solutions
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Matsumoto Kiyoshi
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Apollo Pharmacy
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Service Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. MedPlusMart.com.
7.4.12.1. Overview
7.4.12.2. Financial Performance
7.4.12.3. Service Benchmarking
7.4.12.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global pharmacy market, by product, 2018-2030 (USD Billion)
Table 4 Global pharmacy market, by type, 2018-2030 (USD Billion)
Table 5 Global pharmacy market, by region, 2018-2030 (USD Billion)
Table 6 North America pharmacy market, by country, 2018-2030 (USD Billion)
Table 7 North America pharmacy market, by product, 2018-2030 (USD Billion)
Table 8 North America pharmacy market, by type, 2018-2030 (USD Billion)
Table 9 U.S.pharmacy market, by product, 2018-2030 (USD Billion)
Table 10 U.S pharmacy market, by type, 2018-2030 (USD Billion)
Table 11 Canada pharmacy market, by product, 2018-2030 (USD Billion)
Table 12 Canada pharmacy market, by type, 2018-2030 (USD Billion)
Table 13 Mexico pharmacy market, by product, 2018-2030 (USD Billion)
Table 14 Mexico pharmacy market, by type, 2018-2030 (USD Billion)
Table 15 Europe pharmacy market, by country, 2018-2030 (USD Billion)
Table 16 Europe pharmacy market, by product, 2018-2030 (USD Billion)
Table 17 Europe pharmacy market, by type, 2018-2030 (USD Billion)
Table 18 UK pharmacy market, by product, 2018-2030 (USD Billion)
Table 19 UK pharmacy market, by type, 2018-2030 (USD Billion)
Table 20 Germany pharmacy market, by product, 2018-2030 (USD Billion)
Table 21 Germany pharmacy market, by type, 2018-2030 (USD Billion)
Table 22 France pharmacy market, by product, 2018-2030 (USD Billion)
Table 23 France pharmacy market, by type, 2018-2030 (USD Billion)
Table 24 Italy pharmacy market, by product, 2018-2030 (USD Billion)
Table 25 Italy pharmacy market, by type, 2018-2030 (USD Billion)
Table 26 Spain pharmacy market, by product, 2018-2030 (USD Billion)
Table 27 Spain pharmacy market, by type, 2018-2030 (USD Billion)
Table 28 Sweden pharmacy market, by product, 2018-2030 (USD Billion)
Table 29 Sweden pharmacy market, by type, 2018-2030 (USD Billion)
Table 30 Norway pharmacy market, by product, 2018-2030 (USD Billion)
Table 31 Norway pharmacy market, by type, 2018-2030 (USD Billion)
Table 32 Denmark pharmacy market, by product, 2018-2030 (USD Billion)
Table 33 Denmark pharmacy market, by type, 2018-2030 (USD Billion)
Table 34 Asia Pacific pharmacy market, by country, 2018-2030 (USD Billion)
Table 35 Asia Pacific pharmacy market, by product, 2018-2030 (USD Billion)
Table 36 Asia Pacific pharmacy market, by type, 2018-2030 (USD Billion)
Table 37 Japan pharmacy market, by product, 2018-2030 (USD Billion)
Table 38 Japan pharmacy market, by type, 2018-2030 (USD Billion)
Table 39 China pharmacy market, by product, 2018-2030 (USD Billion)
Table 40 China pharmacy market, by type, 2018-2030 (USD Billion)
Table 41 India pharmacy market, by product, 2018-2030 (USD Billion)
Table 42 India pharmacy market, by type, 2018-2030 (USD Billion)
Table 43 Australia pharmacy market, by product, 2018-2030 (USD Billion)
Table 44 Australia pharmacy market, by type, 2018-2030 (USD Billion)
Table 45 Thailand pharmacy market, by product, 2018-2030 (USD Billion)
Table 46 Thailand pharmacy market, by type, 2018-2030 (USD Billion)
Table 47 South Korea pharmacy market, by product, 2018-2030 (USD Billion)
Table 48 South Korea pharmacy market, by type, 2018-2030 (USD Billion)
Table 49 Latin America pharmacy market, by country, 2018-2030 (USD Billion)
Table 50 Latin America pharmacy market, by product, 2018-2030 (USD Billion)
Table 51 Latin America pharmacy market, by type, 2018-2030 (USD Billion)
Table 52 Brazil pharmacy market, by product, 2018-2030 (USD Billion)
Table 53 Brazil pharmacy market, by type, 2018-2030 (USD Billion)
Table 54 Argentina pharmacy market, by product, 2018-2030 (USD Billion)
Table 55 Argentina pharmacy market, by type, 2018-2030 (USD Billion)
Table 56 Middle East & Africa pharmacy market, by country, 2018-2030 (USD Billion)
Table 57 Middle East & Africa pharmacy market, by product, 2018-2030 (USD Billion)
Table 58 Middle East & Africa pharmacy market, by type, 2018-2030 (USD Billion)
Table 59 South Africa pharmacy market, by product, 2018-2030 (USD Billion)
Table 60 South Africa pharmacy market, by type, 2018-2030 (USD Billion)
Table 61 Saudi Arabia pharmacy market, by product, 2018-2030 (USD Billion)
Table 62 Saudi Arabia pharmacy market, by type, 2018-2030 (USD Billion)
Table 63 UAE pharmacy market, by product, 2018-2030 (USD Billion)
Table 64 UAE pharmacy market, by type, 2018-2030 (USD Billion)
Table 65 Kuwait pharmacy market, by product, 2018-2030 (USD Billion)
Table 66 Kuwait pharmacy market, by type, 2018-2030 (USD Billion)
List of Figures
Figure 1 Market research process
Figure 2 Pharmacy market segmentation
Figure 3 Market research process
Figure 4 Data triangulation techniques
Figure 5 Primary research pattern
Figure 6 Market research approaches
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD modelling for market share assessment
Figure 9 Market formulation & validation
Figure 10 Market snapshot
Figure 11 Market segmentation
Figure 12 Competitive landscape
Figure 13 Global pharmacy market lineage outlook
Figure 14 Pharmacy market dynamics
Figure 15 Market driver relevance analysis (Current & future impact)
Figure 16 Market restraint relevance analysis (Current & future impact)
Figure 17 Pharmacy market: Porter’s five forces analysis
Figure 18 Pharmacy market: PESTLE analysis
Figure 19 Pharmacy market product outlook: Segment dashboard
Figure 20 Pharmacy market: Product movement & market share analysis, 2023 & 2030
Figure 21 Prescription market, 2018-2030 (USD Million)
Figure 22 OTC market, 2018-2030 (USD Million)
Figure 23 Pharmacy market type outlook: Segment dashboard)
Figure 24 Pharmacy market: type movement & market share analysis, 2023 & 2030
Figure 25 Hospital pharmacy market, 2018-2030 (USD Billion)
Figure 26 Retail pharmacy market, 2018-2030 (USD Billion)
Figure 27 Chain pharmacy market, 2018-2030 (USD Billion)
Figure 28 Independent pharmacy market, 2018-2030 (USD Billion)
Figure 29 Other retail pharmacy market, 2018-2030 (USD Billion)
Figure 30 ePharmacy market, 2018-2030 (USD Billion)
Figure 31 Other pharmacy market, 2018-2030 (USD Billion)
Figure 32 Regional marketplace: Key takeaways
Figure 33 North America pharmacy market, 2018-2030 (USD Billion)
Figure 34 U.S key country dynamics
Figure 35 U.S pharmacy market, 2018-2030 (USD Billion)
Figure 36 Canada key country dynamics
Figure 37 Canada pharmacy market, 2018-2030 (USD Billion)
Figure 38 Mexico key country dynamic
Figure 39 Mexico pharmacy market, 2018-2030 (USD Billion)
Figure 40 Europe pharmacy market, 2017-2030 (USD Billion)
Figure 41 UK key country dynamic
Figure 42 UK pharmacy market, 2018-2030 (USD Billion)
Figure 43 Germany key country dynamic
Figure 44 Germany pharmacy market, 2018-2030 (USD Billion)
Figure 45 France key country dynamic
Figure 46 France pharmacy market, 2018-2030 (USD Billion)
Figure 47 Italy key country dynamic
Figure 48 Italy pharmacy market, 2018-2030 (USD Billion)
Figure 49 Spain key country dynamic
Figure 50 Spain pharmacy market, 2018-2030 (USD Billion)
Figure 51 Denmark key country dynamic
Figure 52 Denmark pharmacy market, 2018-2030 (USD Billion)
Figure 53 Sweden key country dynamic
Figure 54 Sweden pharmacy market, 2018-2030 (USD Billion)
Figure 55 Norway key country dynamic
Figure 56 Norway pharmacy market, 2018-2030 (USD Billion)
Figure 57 Asia Pacific pharmacy market, 2018-2030 (USD Billion)
Figure 58 China key country dynamic
Figure 59 China pharmacy market, 2018-2030 (USD Billion)
Figure 60 Japan key country dynamic
Figure 61 Japan pharmacy market, 2018-2030 (USD Billion)
Figure 62 India key country dynamic
Figure 63 India pharmacy market, 2018-2030 (USD Billion)
Figure 64 South Korea key country dynamic
Figure 65 South Korea pharmacy market, 2018-2030 (USD Billion)
Figure 66 Australia key country dynamic
Figure 67 Australia pharmacy market, 2018-2030 (USD Billion)
Figure 68 Thailand key country dynamic
Figure 69 Thailand pharmacy market, 2018-2030 (USD Billion)
Figure 70 Latin America pharmacy market, 2018-2030 (USD Billion)
Figure 71 Brazil key country dynamic
Figure 72 Brazil pharmacy market, 2018-2030 (USD Billion)
Figure 73 Argentina key country dynamic
Figure 74 Argentina pharmacy market, 2018-2030 (USD Billion)
Figure 75 MEA pharmacy market, 2018-2030 (USD Billion)
Figure 76 South Africa key country dynamic
Figure 77 South Africa pharmacy market, 2018-2030 (USD Billion)
Figure 78 Saudi Arabia key country dynamic
Figure 79 Saudi Arabia pharmacy market, 2018-2030 (USD Billion)
Figure 80 UAE key country dynamic
Figure 81 UAE pharmacy market, 2018-2030 (USD Billion)
Figure 82 Kuwait key country dynamic
Figure 83 Kuwait pharmacy market, 2018-2030 (USD Billion)
Figure 84 Company categorization
Figure 85 Company market position analysis
Figure 86 Strategic framework

Companies Mentioned

  • CVS Health
  • Boots Walgreens
  • Cigna
  • Walmart
  • Kroger
  • Rite Aid Corporation
  • Lloyd Pharmacy
  • Well Pharmacy
  • Humana Pharmacy Solutions
  • Matsumoto Kiyoshi
  • Apollo Pharmacy
  • MedPlusMart.com.

Methodology

Loading
LOADING...

Table Information